Compugen Stock Transferred to Nasdaq Capital Market | GenomeWeb

NEW YORK (GenomeWeb News) – Compugen today said that its application to transfer its common stock from the Nasdaq Global Market to the Nasdaq Capital Market has been approved by the exchange.

The transfer was effective as of the opening of the stock market this morning. Compugen's shares continue to trade under the symbol "CGEN."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.